The Chinese gastrointestinal (GI) endoscopic device market includes GI endoscopes, capsule endoscopes, stenting devices, dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, hemostasis devices and enteral feeding devices. High demand for GI screening and intervention procedures due to the aging population and growing awareness will drive market growth. Over the 20112018 forecast period, market expansion will be fueled by procedural growth and a higher incidence of GI disease; this will result in market growth accelerating gradually over the forecast period.
GI endoscopy is one of the most widely performed medical procedures in the United States. The majority of these procedures are screenings related to colon cancer or the removal of abnormalities from the GI tract. It is important to note that there is significant overlap between the procedures considered and a patient can, and often
In 2018, the largest segment was the specimen retrieval device market, which accounted for the majority of the total market value. Growth of this market is primarily driven by the polyp retrieval trap segment, which is a low-cost alternative to specimen retrieval nets. Specimen retrieval devices are used for retrieving tissue samples or excised polyps
In 2018, the largest segment in the stenting and dilation device market was esophageal dilation balloons. The relatively large size of this segment is mainly due to a significantly higher rate of dilation balloon usage within esophagogastroduodenoscopy (EGD) procedures compared to colonoscopy and enteroscopy. Stents are used for treating conditions obstructing the gastrointestinal tract. These
The market units are expected to continue growing in line with the macro trends, such as the aging population and growing popularity of screening programs. The prices, however, are generally trending down, fueled by negative reimbursement changes. Overall, the GI endoscope market is expected to grow steadily at a single-digit rate over the forecast period.
The value of the enteral feeding pump increased in 2018, and growth is expected to continue over the forecast period, driven by increasing unit sales and moderated by ASP depreciation. The majority of unit sales consisted of portable devices sold into homecare and hospital markets and mainly indicated for continuous feeding. Enteral feeding devices are
Overall, the European gastrointestinal endoscopic devices market was valued at nearly 1.2 billion in 2019. This is expected to increase over the forecast period at a CAGR of 2.3% to reach just under 1.4 billion. The saturated nature of the European market for GI endoscopic devices will somewhat limit growth over the forecast period. Reimbursement
This Global Report Series represents iData’s entire collection of country-level reports in the Gastrointestinal (GI) Endoscopy Devices Market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s base year: United States (2019) Europe (2019) China (2020) US Gastrointestinal
Overall, the U.S. GI endoscopic device market was valued at over $2.9 billion in 2018. This is expected to increase over the forecast period at a CAGR of 3.5% to exceed $3.7 billion. As the demand side of the market continues to undergo consolidation with hospitals acquiring outpatient facilities and expanding the reach of the
Industry Trends Capsule endoscopy was first introduced in the U.S. in 2001 by Given Imaging, an Israeli company based in Yokneam, Israel. Modeled after advanced missile guidance technology, capsule endoscopy allows patients to undergo diagnostic procedures without any of the discomfort associated with conventional endoscopies. These procedures are noninvasive and typically painless. From 2001 to